Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,917Revenue $M0.0Net Margin (%)0Z-Score-9.3
Enterprise Value $M2,953EPS $-0.6Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $-1.1Pre-tax Margin (%)0Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %-19.2Quick Ratio0.4Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %-25.6Current Ratio0.4Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-74.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M389ROI % (ttm)-83.8Gross Margin Increase y-yN

Gurus Latest Trades with MNKD

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MNKDJean-Marie Eveillard 2013-03-31 Sold Out -0.01%$2.31 - $3.56
($2.75)
$ 7.25164%Sold Out0
MNKDJean-Marie Eveillard 2012-12-31 Buy 0.01%$1.85 - $2.83
($2.16)
$ 7.25236%New holding, 800000 sh.800,000
MNKDGeorge Soros 2007-09-30 Sold Out -0.01%$8.87 - $13.09
($10.2)
$ 7.25-29%Sold Out0
MNKDGeorge Soros 2007-06-30 Buy 0.01%$11.46 - $14.95
($13.3)
$ 7.25-46%New holding, 13493 sh.13,493
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MNKD is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


MNKD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Palumbo DianeVice President, Human Resource 2014-08-15Sell18,726$7.013.42 view
Thomson DavidVP & General Counsel 2014-08-07Sell30,000$8.16-11.15 view
Martens JuergenCorporate VP 2014-07-28Sell416$8.55-15.2 view
Martens JuergenCorporate VP 2014-07-21Sell26,458$9.65-24.87 view
Thomson DavidVP & General Counsel 2014-07-17Sell30,000$9.42-23.04 view
Palumbo DianeVice President, Human Resource 2014-07-15Sell17,901$10.01-27.57 view
PFEFFER MATTHEW JCorporate VP and CFO 2014-07-01Sell20,000$10.44-30.56 view
Edstrom HakanPresident & COO 2014-06-30Buy1,692$4.4264.03 view
PFEFFER MATTHEW JCorporate VP and CFO 2014-06-30Buy527$4.4264.03 view
Palumbo DianeVice President, Human Resource 2014-06-30Buy636$4.4264.03 view

Press Releases about MNKD :

    Quarterly/Annual Reports about MNKD:

    News about MNKD:

    Articles On GuruFocus.com
    Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
    Evaluating MannKind (MNKD) & Sanofi (SNY) Agreement for Afrezza Aug 15 2014 
    There is a Tide in the Affairs of MannKind: When Taken At the Flood, Will Lead to Fortune Aug 14 2014 
    What This Upcoming Monday Means For MannKind Shareholders Aug 08 2014 
    Shareholders To Inhale Relief As MannKind Found Its Bright Insulin Supply Partner Amphastar Aug 06 2014 
    Shareholders To Inhale Relief As MannKind Found Its Bright Insulin Supply Partner Amphastar Aug 06 2014 
    Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes Market Jul 29 2014 
    Mannkind Corporation: Safe Labeling, Incentivized Spirometry and Experts Votes of Confidence Jul 25 2014 
    MannKind Corporation: Investors Should Seek Truth As The Requisite To Finding This Alpha Jul 24 2014 
    Recent Tsunami of Insider Shares Purchased: A Prelude To Mannkind Partnership or Acquisition Jul 19 2014 


    More From Other Websites
    MANNKIND CORP Financials Aug 19 2014
    [video] MannKind Snares Sanofi, Intercept Soars & Southwest's Mexico Move Aug 15 2014
    Blame MannKind's Fall on its Bloated Balance Sheet Aug 13 2014
    What the Market is Telling MannKind Aug 13 2014
    Did MannKind Find Right Afrezza Partner in Sanofi? Aug 12 2014
    MannKind Posts Wider Q2 Loss, Up on Sanofi Deal for Afrezza Aug 12 2014
    Sanofi wins right to market MannKind's inhaled insulin drug Afrezza Aug 11 2014
    Mannkind Corp Earnings Call scheduled for 5:00 pm ET today Aug 11 2014
    MannKind Enters into a Global Deal with Sanofi for Afrezza Aug 11 2014
    U.S. small caps lead broad stock-market gains Aug 11 2014
    US STOCKS-Wall St extends gains from Friday in broad rally Aug 11 2014
    US STOCKS-Wall St extends gains from Friday in broad rally Aug 11 2014
    Now Take Deep Breath: MannKind Finds A Partner for Afrezza Aug 11 2014
    Dean Foods Dips On Q2 Results; Kinder Morgan Shares Spike Higher Aug 11 2014
    [video] Sanofi to Pay MannKind as Much as $925M for Afrezza Global Rights Aug 11 2014
    US STOCKS-Wall St up for second straight session in broad rally Aug 11 2014
    US STOCKS-Wall St up for second straight session in broad rally Aug 11 2014
    MannKind Corporation Reports 2014 Second Quarter Financial Results Aug 11 2014
    Breathe Deeply: Sanofi Will Market MannKind's Inhaled Insulin Aug 11 2014
    MannKind Soars on Deal With Sanofi, Investors Say Hold On Aug 11 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide